• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[流式细胞术(FCM)在人子宫颈正常及恶性上皮细胞DNA含量测定中的应用及DNA含量的预后意义——II. 结果]

[Flow cytometry (FCM) in DNA content assay of normal and malignant epithelial cells of human uterine cervix and the prognostic significance of DNA content--II. Results].

作者信息

Wu A R

机构信息

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing.

出版信息

Zhonghua Zhong Liu Za Zhi. 1988 May;10(3):194-6.

PMID:3219979
Abstract

Previous studies on cervical cancer using microspectrophotometric technique to measure DNA content of the cancer cells had indicated that the tumor ploidy is an important prognostic variable and that tumors with a DNA index less than 1.55 have a worse prognosis than those with higher DNA index. But there are conflicting results in the other studies using flow cytometer. In this paper, a retrospective analysis on the tumor ploidy of paraffin-embedded tissues using flow cytometer before treatment in 88 patients with cervical cancer was carried out. The results indicate that tumors with a DNA index over 1.5 have a higher recurrence rate and lower survival rate in stage I patients as compared with tumors having a lower DNA index (P less than 0.05). No correlation is found between clinical stage, tumor size, lymph node metastasis, histopathology and DNA index. However, prognosis is related to many factors, such as tumor differentiation, treatment modality etc., a multiple regression analysis of the different prognostic variables and further studies in this aspect are necessary.

摘要

以往利用显微分光光度测定技术测量宫颈癌细胞DNA含量的研究表明,肿瘤倍体是一个重要的预后变量,DNA指数小于1.55的肿瘤比DNA指数较高的肿瘤预后更差。但其他使用流式细胞仪的研究结果却相互矛盾。本文对88例宫颈癌患者治疗前石蜡包埋组织的肿瘤倍体进行了回顾性分析,采用流式细胞仪检测。结果表明,与DNA指数较低的肿瘤相比,DNA指数超过1.5的肿瘤在I期患者中具有更高的复发率和更低的生存率(P小于0.05)。临床分期、肿瘤大小、淋巴结转移、组织病理学与DNA指数之间未发现相关性。然而,预后与许多因素有关,如肿瘤分化、治疗方式等,有必要对不同的预后变量进行多元回归分析并在这方面做进一步研究。

相似文献

1
[Flow cytometry (FCM) in DNA content assay of normal and malignant epithelial cells of human uterine cervix and the prognostic significance of DNA content--II. Results].[流式细胞术(FCM)在人子宫颈正常及恶性上皮细胞DNA含量测定中的应用及DNA含量的预后意义——II. 结果]
Zhonghua Zhong Liu Za Zhi. 1988 May;10(3):194-6.
2
[Flow cytometry (FCM) in the assay of DNA content of normal and malignant epithelial cells of human uterine cervix and the prognostic significance of DNA content: I. Methodology].[流式细胞术(FCM)检测人子宫颈正常及恶性上皮细胞DNA含量及DNA含量的预后意义:I. 方法学]
Zhonghua Zhong Liu Za Zhi. 1985 Mar;7(2):87-90.
3
Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix.
Gynecol Oncol. 1999 Oct;75(1):20-4. doi: 10.1006/gyno.1999.5520.
4
Flow cytometric evaluation of early invasive cervical cancer.早期浸润性宫颈癌的流式细胞术评估
Obstet Gynecol. 1993 Mar;81(3):367-71.
5
Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix.
Gynecol Oncol. 1999 Nov;75(2):242-7. doi: 10.1006/gyno.1999.5573.
6
DNA content as prognostic factor in cervix carcinoma stage IB-III treated with radiotherapy.
Gynecol Oncol. 1994 Sep;54(3):275-81. doi: 10.1006/gyno.1994.1210.
7
Prognostic significance of DNA content in epithelial ovarian cancer.DNA含量在上皮性卵巢癌中的预后意义。
Gynecol Oncol. 1994 Apr;53(1):5-12. doi: 10.1006/gyno.1994.1078.
8
DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.DNA倍体、增殖指数、分级和分期作为外阴鳞状细胞癌的预后因素。
Gynecol Oncol. 1993 Feb;48(2):232-5. doi: 10.1006/gyno.1993.1039.
9
[The study of DNA ploidy as a prognostic factor in uterine cervical cancer].[DNA倍体作为子宫颈癌预后因素的研究]
Nihon Sanka Fujinka Gakkai Zasshi. 1992 Sep;44(9):1127-34.
10
DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.原发性和复发性头颈部鳞状细胞癌(HNSCC)中的DNA倍体、增殖能力和肿瘤内异质性——对临床管理和治疗决策的潜在影响
Oral Oncol. 2008 Jan;44(1):78-85. doi: 10.1016/j.oraloncology.2006.12.013. Epub 2007 Mar 9.